CCCC vs FAST · rev $35.6M vs P/E 43, rev $7.55B
C4 Therapeutics Inc (CCCC) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
CCCC currently screens at market cap $425.7M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the CCCC and FAST stock pages for the full models.
Not investment advice.